These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9605744)

  • 1. Carcinogens preferentially bind at methylated CpG in the p53 mutational hot spots.
    Chen JX; Zheng Y; West M; Tang MS
    Cancer Res; 1998 May; 58(10):2070-5. PubMed ID: 9605744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential carcinogen-DNA adduct formation at codons 12 and 14 in the human K-ras gene and their possible mechanisms.
    Hu W; Feng Z; Tang MS
    Biochemistry; 2003 Aug; 42(33):10012-23. PubMed ID: 12924950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers.
    Yoon JH; Smith LE; Feng Z; Tang M; Lee CS; Pfeifer GP
    Cancer Res; 2001 Oct; 61(19):7110-7. PubMed ID: 11585742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Methylcytosine in CpG sites and the reactivity of nearest neighboring guanines toward the carcinogen aflatoxin B1-8,9-epoxide.
    Ross MK; Mathison BH; Said B; Shank RC
    Biochem Biophys Res Commun; 1999 Jan; 254(1):114-9. PubMed ID: 9920742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous cytosine methylation and the formation of carcinogen carcinogen-DNA adducts.
    Tretyakova N; Guza R; Matter B
    Nucleic Acids Symp Ser (Oxf); 2008; (52):49-50. PubMed ID: 18776247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of diastereomeric benzo[a]pyrene diol epoxide-guanine adducts in p53 gene-derived DNA sequences.
    Matter B; Wang G; Jones R; Tretyakova N
    Chem Res Toxicol; 2004 Jun; 17(6):731-41. PubMed ID: 15206894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens.
    Puisieux A; Lim S; Groopman J; Ozturk M
    Cancer Res; 1991 Nov; 51(22):6185-9. PubMed ID: 1933877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of UvrABC nuclease to quantify benzo[a]pyrene diol epoxide-DNA adduct formation at methylated versus unmethylated CpG sites in the p53 gene.
    Tang MS; Zheng JB; Denissenko MF; Pfeifer GP; Zheng Y
    Carcinogenesis; 1999 Jun; 20(6):1085-9. PubMed ID: 10357792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete and tissue-independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers.
    Tornaletti S; Pfeifer GP
    Oncogene; 1995 Apr; 10(8):1493-9. PubMed ID: 7731703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of cytosine methylation on the chemoselectivity of benzo[a]pyrene diol epoxide-oligonucleotide adducts determined using nanoLC/MS/MS.
    Glick J; Xiong W; Lin Y; Noronha AM; Wilds CJ; Vouros P
    J Mass Spectrom; 2009 Aug; 44(8):1241-8. PubMed ID: 19536795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-hydroxy-4-aminobiphenyl-DNA binding in human p53 gene: sequence preference and the effect of C5 cytosine methylation.
    Feng Z; Hu W; Rom WN; Beland FA; Tang MS
    Biochemistry; 2002 May; 41(20):6414-21. PubMed ID: 12009904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-CpG cytosine methylation of p53 exon 5 in non-small cell lung carcinoma.
    Kouidou S; Agidou T; Kyrkou A; Andreou A; Katopodi T; Georgiou E; Krikelis D; Dimitriadou A; Spanos P; Tsilikas C; Destouni H; Tzimagiorgis G
    Lung Cancer; 2005 Dec; 50(3):299-307. PubMed ID: 16125822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation and repeats in silent and nonsense mutations of p53.
    Kouidou S; Malousi A; Maglaveras N
    Mutat Res; 2006 Jul; 599(1-2):167-77. PubMed ID: 16620878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similarities in sunlight-induced mutational spectra of CpG-methylated transgenes and the p53 gene in skin cancer point to an important role of 5-methylcytosine residues in solar UV mutagenesis.
    You YH; Pfeifer GP
    J Mol Biol; 2001 Jan; 305(3):389-99. PubMed ID: 11152598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational signature of the proximate bladder carcinogen N-hydroxy-4-acetylaminobiphenyl: inconsistency with the p53 mutational spectrum in bladder cancer.
    Besaratinia A; Bates SE; Pfeifer GP
    Cancer Res; 2002 Aug; 62(15):4331-8. PubMed ID: 12154037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenic potential of benzo[a]pyrene-derived DNA adducts positioned in codon 273 of the human P53 gene.
    Dong H; Bonala RR; Suzuki N; Johnson F; Grollman AP; Shibutani S
    Biochemistry; 2004 Dec; 43(50):15922-8. PubMed ID: 15595848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of 5-methylcytosine in sunlight-induced mutagenesis.
    You YH; Li C; Pfeifer GP
    J Mol Biol; 1999 Oct; 293(3):493-503. PubMed ID: 10543945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytosine methylation in a CpG sequence leads to enhanced reactivity with Benzo[a]pyrene diol epoxide that correlates with a conformational change.
    Weisenberger DJ; Romano LJ
    J Biol Chem; 1999 Aug; 274(34):23948-55. PubMed ID: 10446162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
    Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA damage and mutations produced by chloroacetaldehyde in a CpG-methylated target gene.
    Choi JH; Pfeifer GP
    Mutat Res; 2004 Dec; 568(2):245-56. PubMed ID: 15542111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.